# FDA 483 - Zinoviy T. Benzar, M.D. - December 12, 2025

Source: https://www.keypedia.com/records/483/zinoviy-t-benzar-md/3f22d960-d18c-417d-af79-ae2fa3f6a58c

> FDA 483 for Zinoviy T. Benzar, M.D. on December 12, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Zinoviy T. Benzar, M.D.
- Inspection Date: 2025-12-12
- Product Type: drugs
- Office Name: San Francisco District Office
- Summary: An FDA inspection of Oasis Clinical Research, LLC in Las Vegas, NV, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to investigational plans, enrolling subjects who did not meet eligibility criteria and improperly timing sample collections. Additionally, the inspection found inadequate and inaccurate case histories, with issues related to contemporaneous documentation and data alterations.

## Related Officers

- [Scott N. Lim](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/zinoviy-t-benzar-md/f80445fa-914f-4c2c-816e-4991e35afac5

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df